Development of an ostrich-derived single-chain variable fragment (scFv) against PTPRN extracellular domain
Abstract In type 1 diabetes, the immune system destroys pancreatic beta cells in an autoimmune condition. To overcome this disease, a specific monoclonal antibody that binds to pancreatic beta cells could be used for targeted immunotherapy. Protein tyrosine phosphatase receptor N (PTPRN) is one of t...
Sparad:
| Huvudupphov: | , , , , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
Nature Portfolio
2024-02-01
|
| Serie: | Scientific Reports |
| Länkar: | https://doi.org/10.1038/s41598-024-53386-5 |
| Taggar: |
Inga taggar, Lägg till första taggen!
|